104 results
Page 4 of 6
8-K
EX-10.4
p18fnk
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
DEFM14A
3jivw
6 Nov 18
Proxy related to merger
12:00am
424B3
yrpc7
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
ckek111r3dntqt1oo44
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-2.1
itfo d0a45
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-10.1
ltdg5nvfpmkdx2i
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
ednd30s3
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
wp10fr6vh0tp
9 Aug 18
Business combination disclosure
5:17pm
425
EX-10.1
2xqlpg9o
9 Aug 18
Business combination disclosure
5:17pm
425
fti190oz8ac8ozp
9 Aug 18
Business combination disclosure
5:17pm
8-K
zoszj
3 May 18
OvaScience Reports First Quarter 2018 Financial Results and Provides Business Update
4:53pm